Pharmacovigilance and Drug Safety Software Market Size, Segments, and Trends by 2031
Pharmacovigilance and Drug Safety Software Market: Strategic Insights
Pharmacovigilance and Drug Safety Software Market
-
CAGR (2023 - 2031)6.7% -
Market Size 2023
US$ 214.39 Million -
Market Size 2031
US$ 359.30 Million
Market Dynamics
GROWTH DRIVERS
- Rise in Incidences of Adverse Drug Reactions
- Globalization of Pharmacovigilance
- Surge in Drug Development Spending
FUTURE TRENDS
- Cloud-Based Pharmacovigilance, Drug Safety Software
OPPORTUNITIES
- Integration of Software with AI, ML, and NLP
Key Players
- ArisEurope
- ICON plc
- Syneos Health
- Accenture
- IQVIA
- Genpact
- Cognizant
- Paraxel International Corporation
- Laboratory Corporation of America Holdings
- Max Application
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Offering
- Software
- Services
Deployment
- Cloud
- On Premises
Enterprise Size
- Large Enterprises
- SMEs
Form
- Standard
- Customized